Search

Search Constraints

You searched for: Author/Creator Jones, Richard J.

Search Results

1. A phase II study of azacitidine in combination with granulocyte-macrophage colony-stimulating factor as maintenance treatment, after allogeneic blood or marrow transplantation in patients with poor-risk acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). Issue 13 (10th November 2021)

4. CD34+ cell of origin for immunoglobulin heavy chain variable region unmutated, but not mutated, chronic lymphocytic leukemia. Issue 7 (7th June 2022)

6. Differentiation therapy in poor risk myeloid malignancies: Results of companion phase II studies. (October 2016)

7. Differentiation therapy in poor risk myeloid malignancies: Results of companion phase II studies. (October 2016)

8. Donor Clonal Hematopoiesis and Recipient Outcomes After Transplantation. Issue 2 (10th January 2022)